Long

Akcea and Ionis Report Positive Data from Phase 2 Study

37
AKCA: Akcea Therapeutics, Inc.
2018-09-24 07:00:00
Akcea and Ionis Report Positive Data from Phase 2 Study of AKCEA-APO(a)-LRx

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.